(Q43754793)

26 November 2017

Heart valve involvement in Fabry cardiomyopathy (English)

1 reference

26 November 2017

Frank Weidemann

1

1 reference

26 November 2017

Joerg M Strotmann

2

1 reference

26 November 2017

Markus Niemann

3

1 reference

26 November 2017

Sebastian Herrmann

4

1 reference

26 November 2017

Mario Wilke

5

1 reference

26 November 2017

Meinrad Beer

6

1 reference

26 November 2017

Wolfram Voelker

7

1 reference

26 November 2017

Georg Ertl

8

1 reference

26 November 2017

Andrea Emmert

9

1 reference

26 November 2017

Christoph Wanner

10

1 reference

26 November 2017

Frank Breunig

11

1 reference

26 November 2017

24 December 2008

1 reference

Ultrasound in Medicine and Biology

26 November 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 November 2017

35

1 reference

26 November 2017

5

1 reference

26 November 2017

730-735

1 reference

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Fabry disease: guidelines for the evaluation and management of multi-organ system involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Structural and functional changes in peripheral vasculature of Fabry patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Cardiac manifestations of Anderson-Fabry disease in heterozygous females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

The heart in Anderson-Fabry disease and other lysosomal storage disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Cardiac manifestations in Fabry disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Early Detection of Fabry Cardiomyopathy by Tissue Doppler Imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Fabry Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Extracellular matrix turnover and disease severity in Anderson-Fabry disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2008.10.010

10.1016/J.ULTRASMEDBIO.2008.10.010

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference